Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious

British Medical Bulletin

Volumn 52, Issue 1, 1996, Pages 58-73

  Baron, John A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; PROSTAGLANDIN;

ALZHEIMER DISEASE; APHTHOUS ULCER; BODY WEIGHT; CIGARETTE SMOKING; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE; HUMAN; MATERNAL HYPERTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; UTERUS MYOMA; VOMITING;

EID: 0030065436     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011533     Document Type: Review

References (135)

1. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use. N Engl J Med 1994; 330: 907-12
2. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162: 502-14
3. Wald N, Baron J. Smoking and Hormone-Related Disorders. Oxford: Oxford University Press, 1990
4. Ross RK, Pike MC, Vessey MP et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. BMJ 1986; 293: 359-61
5. Parazzini F, La Vecchia C, Negri E et al. Epidemiologic characteristics of women with uterine fibroids: a case-control study. Obstet Gynecol 1988; 72: 853-7
6. Wyshak G, Frisch RE, Albright NL et al. Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to nonathletes. Br J. Cancer 1986; 54: 841-5
7. Cramer DW, Wilson E, Stillman RJ et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA 1986; 255: 1904-8
8. Darrow SL, Vena JE, Batt RE et al. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 1993; 4: 135-42
9. Matorras R, Ramon O, Rodiquez F et al. Epidemiology of endometriosis in infertile women. Fertil Steril 1995; 63: 34-8
10. Depue RH, Bernstein L, Ross RK et al. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 1987; 156: 1137-41
11. Little RE, Hook EB. Maternal alcohol and tobacco consumption and their association with nausea and vomiting during pregnancy. Acta Obstet Gynecol Scand 1979; 58: 15-17
12. Vellacott ID, Cooke EJA, James CE. Nausea and vomiting in early pregnancy. Int J Gynecol Obstet 1988; 27: 57-62
13. Meyer LC, Peacock JL, Bland JM, Anderson HR. Symptoms and health problems in pregnancy: their association with social factors, smoking, alcohol, caffeine and attitude to pregnancy. J Paediatr Perinat Epidemiol 1994; 8: 145-55
14. Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol 1985; 66: 612-16
15. Weigel MM, Weigel RM. The association of reproductive history, demographic factors, and alcohol and tobacco consumption with the risk of developing nausea and vomiting in early pregnancy. Am J Epidemiol 1988; 127: 562-70
16. Underwood PB, Kesler KF, O'Lane JM, Callagan DA. Parental smoking empirically related to pregnancy outcome. Obstet Gynec 1967; 29: 1-8
17. Duffus GM, MacGillivray I. The incidence of pre-eclamptic toxaemia in smokers and nonsmokers. Lancet 1968; i: 994-5
18. Marcoux S, Brisson J, Fabia J. The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am J Epidemiol 1989; 130: 950-7
19. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266: 237-41
20. Klonoff-Cohen H, Edelstein S, Savitz D. Cigarette smoking and preeclampsia. Obstet Gynecol 1993; 81: 541-4
21. Spmillo A, Capuzzo E, Egbe TO, Nicola S, Piazzi G, Baltaro F. Cigarette smoking in pregnancy and risk of pre-eclampsia. J Human Hypertension 1994; 8: 771-5
22. Andrews J, McGarry JM. A community study of smoking in pregnancy. J Obstet Gynaecol Br Commonwealth 1972; 79: 1057-73
23. Hoff C, Wertel W, Blackburn WR et al. Trend associations of smoking with maternal, fetal, and neonatal morbidity. Obstet Gynecol 1986; 689: 317
24. Savitz DA, Zhang J. Pregnancy-induced hypertension in North Carolina, 1988 and 1989. Am J Public Health 1992; 82:675-9
25. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982; 144: 655-60
26. Backon J. Negative correlation of cigarette smoking and dysmenorrhea: reduced prostaglandin synthesis due to beta-endorphin, nicotine, or acrolein antagonism. Med Hypotheses 1989; 28: 213-14
27. Wood C, Larsen L, Williams R. Social and psychological factors in relation to premenstrual tension and menstrual pain. Aust NZ J Obstet Gynaecol 1979; 19: 111-15
28. Sloss EM, Frerichs RR. Smoking and menstrual disorders. Int J Epidemiol 1983; 12: 107-9
29. Brown S, Vessey M, Stratton I. The influence of method of contraception and cigarette smoking on menstrual patterns. Br J Obstet Gynaecol 1988; 95: 905-10
30. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990; 97: 588-94
31. Parazzini F, Tozzi L, Mezzopane R et al. Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology 1994; 5: 469-72
32. Hook EB, Cross PK. Cigarette smoking and Down syndrome. Am J Hum Genet 1985; 37: 1216-24
33. Hook EB, Cross PK. Maternal cigarette smoking Down syndrome in live births, and infant race. Am J Hum Genet 1988; 42: 482-9
34. Cuckle HS, Alberman E, Wald JN et al. Maternal smoking habits and Down's syndrome. Prenat Diagn 1990; 10: 561-7
35. Van Den Eeden SK, Karagas MR, Daling JR, Vaughan TL. A case-control study of maternal smoking and congenital malformations. Paediatr Perinat Epidemiol 1990; 4: 147-55
36. US Department of Health and Human Services. The Health Consequences of Smoking: 25 Years of Progress. A report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Office on Smoking and Health. DHHS Publication no. (CDC) 89-8411, 1989
37. Vorherr H. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. Am J Obstet Gynecol 1986; 154: 161-79
38. Berkowitz G, Canny PF, Vivolsi VA et al. Cigarette smoking and benign breast disease. J Epidemiol Community Health 1985; 39: 308-13
39. Pastides H, Najjar MA, Kelsey JL. Estrogen replacement therapy and fibrocystic breast disease. Am J Prev Med 1987; 3: 282-6
40. Rohan TE, Baron JA. Cigarette smoking and benign breast disease. In: Wald N, Baron J. eds. Smoking and Hormone-Related Disorders. Oxford: Oxford University Press, 1990: pp 72-80
41. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol 1984; 119: 9-22
42. MacMahon B. Cigarette smoking and cancer of the breast. In: Wald N, Baron J. eds. Smoking and Hormone-Related Disorders. Oxford: Oxford University Press, 1990: pp 154-66
43. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 1993; 15: 145-56
44. Meara J. McPherson K, Roberts M et al. Alcohol, cigarette smoking and breast cancer. Br J Cancer 1989; 60: 70-3
45. Weiss NS. Cigarette smoking and the incidence of endometrial cancer. In: Wald N, Baron J. eds. Smoking and Hormone-Related Disorders. Oxford: Oxford University Press, 1990: pp 145-53
46. Garland C, Barrett-Connor E, Rossof AH. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; i: 307-9
47. Sandler RS, Sandier DP, Comstock GW et al. Cigarette smoking and the risk of colorectal cancer in women. J Natl Cancer Inst 1988; 80: 1329-33
48. Baron JA, Sandier RS. Cigarette smoking and cancer of the large bowel. In: Wald N, Baron J. eds. Smoking and Hormone-Related Disorders. Oxford: Oxford University Press, 1990: pp 167-80
49. Baron JA, Gerhardsson de Verdier M, Ekbom A. Coffee, tea, tobacco, and cancer of the large bowel. Cancer Epidemiol Biomarkers Prevention 1994; 3: 565-70
50. Giovanucci E, Rimm EB, Stampfer MJ et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994; 86: 183-91
51. Pinczowski D, Ekbom A, Baron J et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994; 107: 117-20
52. Barbash GI, White HD, Modan M et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation 1993; 87: 53-8
53. Handley AJ, Teather D. Influence of smoking on deep vein thrombosis after myocardial infarction. BMJ 1974; 3: 230-1
54. Emerson PA, Marks P. Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking BMJ 1977; 1: 18-20
55. Marks P, Emerson PA. Increased incidence of deep vein thrombosis after myocardial infarction in non-smokers. BMJ 1977; 3: 232-4
56. Clayton JK, Anderson JA, McNicol GP. Effect of cigarette smoking on subsequent postoperative thromboembolic disease in gynaecological patients. BMJ 1978; 2: 402
57. Prescott RJ, Jones DRB, Vasilescu CV et al. Smoking and risk factors in deep vein thrombosis. Thrombos Haemostas 1978; 40: 128-33
58. Crandon AJ, Koutts J. Incidence of post-operative deep vein thrombosis in gynaecological oncology. Aust NZ J Obstet Gynaecol 1983; 23: 216-19
59. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. BMJ 1969; 2: 651-7
60. Stolley PD, Tonascia JA, Tockman MS et al. Thrombosis with low-estrogen oral contraceptives. XXX 1975; 102: 197-208
61. Hayes MJ, Morris GK, Hampton JR. Lack of effect of bed rest and cigarette smoking on development of deep venous thrombosis after myocardial infarction. Br Heart J 1976; 38: 981-3
62. Petitti DB, Wingerd J, Pellegrin F, Ramcharan S. Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. Am J Epidemiol 1978; 108: 480-5
63. Vandenbroucke JP, Koster T, Briet E et al. Increased risk of venous thrombosis in oralcontraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-7
64. Arrhes FG. An epidemiologic survey of hospitalized cases of venous thrombosis and pulmonary embolism in young women. Milbank Q 1972; 50 (Suppl 2): 233-43
65. Samkoff JS, Comstock GW. Epidemiology of pulmonary embolism: mortality in a general population. Am J Epidemiol 1981; 114: 488-96
66. Goldhaber SZ, Savage DD, Garrison RJ et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983; 74: 1023-8
67. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988; 115: 267-71
68. Jeremy JY, Mikhailidis DP. Smoking and vascular prostanoids: relevance to the pathogenesis of atheroma and thrombosis. J Smoking-Related Dis 1990; 1: 59-69
69. Benowitz NL, FitzGerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostasis function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993; 22: 1159-67
70. Ylikorkala O, Viinikka L, Lehtovirta P. Effect of nicotine on fetal prostacyclin and thromboxane in humans. Obstet Gynecol 1985; 66: 102-5
71. Goerig M, Ullrich V, Schettler G et al. A new role for nicotine: selective inhibition of thromboxane formation by direct interaction with thromboxane synthase in human promyelocytic leukaemia cells differentiating into macrophages. Clin Invest 1992; 70: 239-43
72. Saareks V, Riutta A, Much I et al. Nicotine and cotinine modulate eicosanoid production in human leukocytes and platelet rich plasma. Eur J Pharmacol 1993; 248: 345-9
73. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987; 42: 241-9
74. Shapiro S, Olson DL, Chellemi SJ. The association between smoking and aphthous ulcers. Oral Surg Oral Med Oral Pathol 1970; 30: 624-30
75. Axell T, Henricsson V. Association between recurrent aphthous ulcers and tobacco habits. Scand J Dent Res 1985; 93: 239-42
76. Zain RB, Razak IA. Association between cigarette smoking and prevalence of oral mucosal lesions among Malaysian army personnel. Community Dent Oral Epidemiol 1989; 17: 148-9
77. Grady D, Ernster VL, Stillman L, Greenspan J. Smokeless tobacco use prevent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992; 74: 463-5
78. Bookman R. Relief of canker sores on resumption of cigarette smoking. California Med 1960; 93: 235
79. Sallay K, Banoczy J. Remarks on the possibilities of the simultaneous occurrence of hyperkeratosis of the mucous membranes and recurrent aphthae. Oral Surg 1968; 25: 171-5
80. Bittoun R. Recurrent aphthous ulcers and nicotine. Med J Aust 1991; 154: 471-2
81. Axell T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990; 48: 119-23
82. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54
83. Thomas GAO, Rhodes J. Relationship between smoking, nicotine and ulcerative colitis. In: Clarke PBS, Quik M, Adlkofer F, Thurau K. eds. Effects of Nicotine on Biological Systems II. Basel: Birkhauser, 1995: pp 287-91
84. De Castella H. Non-smoking: a feature of ulcerative colitis (letter). BMJ 1982; 284: 1706
85. Roberts CJ, Diggle R. Non-smoking: a feature of ulcerative colitis. BMJ 1982; 285: 440
86. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients. Dig Dis Sci 1990; 35: 827-32
87. Pullan RD, Rhodes J, Ganesh S et al. Transdermal nicotine for active ulcerative colitis. N EnglJ Med 1994; 330: 811-15
88. Thomas GAO, Rhodes J, Mani V et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995; 332: 988-92
89. Rhodes J, Thomas GAO. Smoking: good or bad for inflammatory bowel disease? Gastroenterology 1994; 106: 807-10
90. Warren CPW. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977; 32: 567-9
91. Gruchow HW, Hoffmann RG, Marx JJ et al. Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis 1981; 124: 411-15
92. McShany C, Banham SW, Boyd G. Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy 1985; 15: 487-94
93. Terho EO, Husman K, Vohlonen I. Prevalence and incidence of chronic bronchitis and farmer's lung with respect to age, sex, atopy, and smoking. Eur J Resp Dis 1987; 152 (Suppl): 1-28
94. Cormier Y, Belanger J, Durand P. Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax 1985; 40: 138-42
95. Terho EO, Husman K, Vohlonen I, Mantyjarvi RA. Serum precipitins against microbes in mouldy hay with respect to age, sex, atopy, and smoking of farmers. Eur J Resp Dis 1987; 152 (Suppl): 115-21
96. Kusaka H, Homma Y, Ogasawara H et al. Five-year follow-up of Micropolyspora faeni antibody in smoking and nonsmoking farmers. Am Rev Respir Dis 1989; 140: 695-9
97. Bakke P, Gulsvik A, Eide GE. Hay fever, eczema and urticaria in southwest Norway. Allergy 1990; 45: 515-22
98. Burrows B, Lebowitz MD, Barbee RA. Respiratory disorders and allergy skin-test reactions. Ann Intern Med 1976; 84: 134-9
99. Oryszczyn M-P, Annesi I, Neukirch F et al. Relationships of total IgE level, skin prick test response, and smoking habits. Ann Allergy 1991; 67: 355-8
100. Milk CM, Hill SA, Marks R. Altered inflammatory responses in smokers. BMJ 1993; 307: 911
101. Comstock GW, Keltz H, Sencer DJ. Clay eating and sarcoidosis. Am Rev Respir Dis 1961; 84 (Suppl): 130-4
102. Terris M, Chaves AD. An epidemiologic study of sarcoidosis. Am Rev Respir Dis 1966; 94: 50-5
103. Douglas JG, Middleton WG, Gaddie J et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986; 41: 787-91
104. Harf RA, Ethevenaux C, Gleize J et al. Reduced prevalence of smokers in sarcoidosis. Ann NY Acad Sci 1986; 145: 625-31
105. Hance AJ, Basset F, Aumon G et al. Smoking and interstitial lung disease. Ann NY Acad Sci 1986; 145: 643-56
106. Revsbech P. Is sarcoidosis related to exposure to pets or the housing conditions? A case-referent study. Sarcoidosis 1992; 9: 101-3
107. Bresnitz EA, Stolley PD, Israel HL, Soper K. Possible risk factors for sarcoidosis. Ann NY Acad Sci 1986; 145: 632-42
108. Mills CM, Peters TJ, Finlay AY. Does smoking influence acne? Clin Exp Dermatol 1993; 18: 100-1
109. US Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. A report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Office on Smoking and Health. DHHS Publication no (CDC) 88-8406, 1988
110. Grunberg NE. The inverse relationship between tobacco use and body weight. In: Kozlowski LT, Annis HM, Cappel HD et al. eds. Research Advances in Alcohol and Drug Problems, vol 10. New York: Plenum, 1990: pp 273-315
111. Hofstetter A, Schutz Y, Jéquier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med 1986; 314: 79-82
112. Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG. The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 1989; 320: 898-903
113. Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG. The effects of nicotine on resting metabolic rate in cigarette smokers. Am J Clin Nutr 1989; 50: 545-50
114. Leutje CW, Patrick J, Seguela P. Nicotine receptors in the mammalian brain. FASEBJ 1990; 4: 2753-60
115. 3H]-nicotine binding sites in human brain. J Neurochem 1988; 50: 1243-7
116. Rowell RP. Current concepts on the effects of nicotine on neurotransmitter release in the central nervous system. In: Martin WK, VanLoon GR, Iwamoto ET, Davis L. eds. Tobacco Smoking and Nicotine. New York: Plenum, 1987: pp 191-208
117. Baron JA. Cigarette smoking and Parkinson's disease. Neurology 1986; 36: 1490-6
118. Graves AB, Mortimer, JA. Does smoking reduce the risk of Parkinson's and Alzheimer's diseases? J Smoking Related Dis 1994; 5 (Suppl 1): 79-90
119. Baron JA. The epidemiology of cigarette smoking and Parkinson's disease. In: Clarke PBS, Quik M, Adlkofer F, Thurau K. eds. Effects of Nicotine on Biological Systems II. Basel: Birkhauser, 1995: pp 313-19
120. Janson AM, Meana JJ, Goiny M, Herrera-Marschitz M, Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transaction at the mesodiencephalic junction in rats: a microdialysis study. Neurosci Lett 1991; 134: 88-92
121. Sershen H, Hashim A, Lajtha A. Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease. Pharmacol Biochem Behav 1987; 28: 299-303
122. Carr LA, Rowell PP. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke. Neuropharmacology 1990; 29: 311-14
123. Shahi GS, Das N, Moochhala SM. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C%&BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatment. Neurosci Lett 1991; 127: 247-50
124. Ishikawa A, Miyatake T. Effects of smoking in patients with early-onset Parkinson's disease. J Neurol Sci 1993; 117: 28-32
125. Fagerström KO, Pomerleau O, Giordani B, Stelson F. Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 1994; 116: 117-19
126. Newhouse PA, Hughes JR. The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addict 1991; 86: 521-6
127. Graves AB, van Duijn CM, Chandra V et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20 (Suppl 2): S48-S57
128. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992; 14: 59-82
129. Jones GMM, Sahakian BJ, Levy R et al. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 1992; 108: 485-94
130. Newhouse PA, Potter A, Piasecki M et al. Nicotinic modulation of cognitive functioning in humans. In: Clarke PBS, Quik M, Adlkofer F, Thurau K. eds. Effects of Nicotine on Biological Systems II. Basel: Birkhauser, 1995: pp 345-51
131. Wesnes K, Warburton DM. Smoking nicotine and human performance. Pharmacol Ther 1983; 21: 189-208
132. Levin ED. Nicotinic systems and cognitive function. Psychopharmacology 1992; 108: 417-31
133. Heishman SJ, Taylor RC, Henningfield JE. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 1994; 2: 345-95
134. Wesnes K. Nicotine increases mental efficiency: but how? In: Martin WR, Van Loon GR, Iwamoto ET, Davis L. eds. Tobacco Smoking and Nicotine: A Neurobiological Approach. New York: Plenum, 1987: pp 63-79
135. Le Houezec J, Halliday R, Benowitz NL, Callaway E, Naylor H, Herzig K. A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology 1994; 114: 628-34